First-line avelumab treatment in patients with metastatic Merkel cell carcinoma: 4-year follow-up from part B of the JAVELIN Merkel 200 study - D'Angelo, Sandra P.; Lebbé, C.; Mortier, L.; Brohl, A. S.; Fazio, N.; Grob, J. -J.; Prinzi, N.; Hanna, G. J.; Hassel, Jessica C.; Kiecker, F.; von Heydebreck, A.; Güzel, G.; et al. (ESMO open, 2024)
Online verfügbar: 13. Mai 2024